Pediatric, Perinatal and Diagnostic Pathology

Biography

Biography: Hiba Ahmed Alsheekh Awooda Mohamed

Abstract

Role of nitric oxide (NO) inhibition in cerebral ischemia/reperfusion (I/R) remains uncertain; this work aimed to explore the neuroprotective potential of N-Nitro-L-Arginine-Methylester (L-NAME) non-selective NO synthase (NOS) inhibitors.The study involved 30 adult male Wistar rats (150-250g), divided into three groups;10 rats in each: sham-operated group (control), I/R group: infused with 0.9% normal saline intraperitoneally prior to 30 minutes of left common carotid artery occlusion followed by 24-hour of reperfusion, third group (test group): infused with L-NAME (15 mg/kg per weight) intraperitoneally 15 minutes prior to the same I/R period. Neurobehavioral assessments were evaluated using six clinical tests. Proper anesthesia was induced. Western blotting was used to estimate Nuclear factor kappa B (NF-Ò›B), Tumor necrosis factor-α (TNF-α) using ELISA and NO metabolites (nitrite and nitrate), were measured colorimetrically in both plasma and affected cerebral hemisphere. Result shows that L-NAME group demonstrates a significant improvement in neurological deficit (P <0.001) compared to both I/R and control groups. In I/R rats NF-Ò›B was significantly increased compared to the control group and L-NAME pretreatment resulted in a significant decrease in NF-Ò›B (P <0.001) compared to I/R group. Serum level of TNF-α and NO were significantly increased in I/R group compared to the control group (P <0.001), while L-NAME administration resulted in a significant decrease in serum TNF-α and NO (P <0.001) compared to the I/R group. In conclusions L-NAME pretreatment for rats undergoing cerebral ischemia/reperfusion significantly improve neurological deficit through it is anti-inflammatory effect in a rat’s model of transient focal cerebral ischemia reperfusion.